Cystic fibrosis: A decade of progress

Drugs of Today

Volumn 35, Issue 11, 1999, Pages 835-848

  Allen, Elizabeth D ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DORNASE ALFA; IBUPROFEN; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AUTOPSY; AUTOSOMAL RECESSIVE DISORDER; CAUSE OF DEATH; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; GENE EXPRESSION; GENE THERAPY; HUMAN; IMMUNE RESPONSE; MALNUTRITION; MASS SCREENING; PANCREAS INSUFFICIENCY; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; REVIEW; STAPHYLOCOCCUS AUREUS; SURVIVAL TIME; THORAX RADIOGRAPHY;

EID: 0033388777     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1999.35.11.562557     Document Type: Review

References (71)

1. Andersen, D.H. Cystic fibrosis of the pancreas and its relation to celiac disease. Am J Dis Child 1938, 56: 344-99.
2. di Sant'Agnese, P.A., Darling, R.C., Perera, G.A., Shea, E. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas. Pediatrics 1953, 12: 549-63.
3. Cystic Fibrosis Foundation. Patient Registry 1997 Annual Data Report, Bethesda, Maryland, 1998.
4. Davis, P.B., Drumm, M., Konstan, M.W. Cystic fibrosis. Am J Respir Crit Care Med 1996, 154: 1229-56.
5. Matsui, H., Grubb, B.R., Tarran, R. et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998, 95: 1005-15.
6. Guggino, W.B. Cystic fibrosis and the salt controversy. Cell 1999, 96: 607-10.
7. Ramsey, B.W. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996, 335: 179-88.
8. Marshall, B.C., Samuelson, W.M. Basic therapies in cystic fibrosis. Does standard therapy work? Clin Chest Med 1998, 19: 487-504.
9. Cystic Fibrosis Foundation. Clinical Practice Guidelines for Cystic Fibrosis, Bethesda, Maryland, 1997.
10. Malfroot, A., Dab, I. New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up. Arch Dis Child 1991, 66: 1339-45.
11. Gustafsson, P.K., Fransson, S.G., Kjellman, J.I., Tibbling, L. Gastro-oesophageal reflux and severity of pulmonary disease in cystic fibrosis. Scand J Gastroenterol 1991, 26: 449-56.
12. Milla, C.E., Wielinski, C.L., Regelmann, W.E. Clinical significance of the recovery of Aspergillus species from the respiratory secretions of cystic fibrosis patients. Pediatr Pulmonol 1996, 21: 6-10.
13. Mepomuceno, I.B., Esrig, S., Moss, R.B. Allergic bronchopulmonary aspergillosis in cystic fibrosis: Hole of atopy and response to itraconazole. Chest 1999, 115: 364-70.
14. Hutcheson, P.S., Knutsen, A.P., Rejent, A.J., Slavin, R.G. A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis. Chest 1996, 110: 363-6.
15. LiPuma, J.J. Burkholderia cepacia management issues and new insights. Clin Chest Med 1998, 19: 473-86.
16. Schidlow, D.V., Taussig, L.M., Knowles, M.R. Cystic fibrosis foundation consensus conference report on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 1993, 15: 187-98.
17. Ramsey, B., Richardson, M.A. Impact of sinusitis in cystic fibrosis. J Allergy Clin Immunol 1992, 90(3, Pt 2): 547-52.
18. Isaacson, G., Yanagisawa, E. Cystic fibrosis and sinusitis. Ear Nose Throat J 1998, 77: 886-8.
19. Halvorson, D.J., Dupree, J.R., Porubsky, E.S. Management of chronic sinusitis in the adult cystic fibrosis patient. Ann Otol Rhinol Laryngol 1998, 107: 946-52.
20. Riedel, B.D. Gastrointestinal manifestations of cystic fibrosis. Pediatr Ann 1997, 26: 235-41.
21. Smyth, R.L. Fibrosing colonopathy in cystic fibrosis. Arch Dis Child 1996, 74: 164-8.
22. Tran, T.M., Van den Neucker, A., Hendriks, J.J., Forget, P., Forget, P.P. Effects of proton-pump inhibitor in cystic fibrosis. Acta Paediatr 1998, 87: 553-8.
23. MacDonald, A. Nutritional management of cystic fibrosis. Arch Dis Child 1996, 74: 81-7.
24. Binkovitz, L.A., Allen, E., Bloom, D. et al. Atypical presentation of Clostridium difficile colitis in patients with cystic fibrosis. AJR Am J Roentgenol 1999, 172: 517-21.
25. Rivlin, J., Lemer, A., Augarten, A., Wilschansid, M., Kerem, E., Ephros, M.A. Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis. J Pediatr 1998, 132: 177-9.
26. Colombo, C., Battezzati, P.M., Strazzabosco, M., Podda, M. Liver and biliary problems in cystic fibrosis. Semin Liver Dis 1998, 18: 227-35.
27. Hamberger, L., Sjogren, A., Lundin, K. et al. Microfertilization techniques: The Swedish experience. Reprod Fertil Dev 1995, 7: 263-7.
28. Phillipson, G. Cystic fibrosis and reproduction. Reprod Fertil Dev 1998, 10: 113-19.
29. Kopito, L.E., Kosasky, H.J., Shwachman, H. Water and electrolytes in cervical mucus from patients with CF. Fertil Steril 1973, 24: 512-6.
30. Johannesson, M., Landgren, B.M., Csemiczky, G., Hjelte, L., Gottleib. C. Female patients with cystic fibrosis suffer from reproductive endocrinological disorders despite good clinical status. Hum Reprod 1998, 13: 2092-7.
31. Hilman, B.C., Aitken, M.L., Constantinescu, M. Pregnancy in patients with cystic fibrosis. Clin Obstet Gynecol 1996, 39: 70-86.
32. Lanng, S., Thorsteinsson, B., Nerup, J., Koch, C. Diabetes mellitus in cystic fibrosis: Effect of insulin therapy on lung function and infections. Acta Paediatr 1994, 83: 849-53.
33. Moran, A., Doherty, L., Wang, X., Thomas, W. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998, 133: 10-7.
34. Wulffraat, N.K., de Graeff-Meeder, E.R., Rijkers, G.T., van der Laag, H., Kuis, W. Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis. J Pediatr 1994, 125: 374-8.
35. Ott, S.M., Aitken, M.L. Osteoporosis in patients with cystic fibrosis. Clin Chest Med 1998, 19: 555-67.
36. Fuchs, H.J., Borowitz, D.S., Christiansen, D.H. et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994, 331: 637-42.
37. Geller, D.E. Aerosolized dornase alfa in cystic fibrosis: Is there a role in the management of patients with early obstructive lung disease? Pediatr Pulmonol 1997, 24: 155-8.
38. Konstan, M.W., Byard, P.J., Hoppel, C.L., Davis, P.B. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995, 332: 848-54.
39. Ramsey, B.W., Pepe, M.S., Quan, J.M. et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999, 340: 23-30.
40. Zuckerman, J.B., Kotloff, R.M. Lung transplantation for cystic fibrosis. Clin Chest Med 1998, 19: 535-54.
41. Yankaskas, J.R., Mallory, G.B. Jr. Lung transplantation in cystic fibrosis. Consensus conference statement. Chest 1998, 113: 217-26.
42. St. Louis International Lung Transplant Registry: January 1997 Report. Washington University School of Medicine, 1997.
43. Milla, C.E., Warwick, W.J. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998, 113, 1230-34.
44. 1 may adversely affect overall survival. Chest 1999, 115: 782-7.
45. Kerem, E., Reisman, J., Corey, M., Canny, G.J., Levison, H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992, 326: 1187-91.
46. Barbers, R.G. Cystic fibrosis: Bilateral living lobar versus cadaveric lung transplantation. Am J Med Sci 1998, 315: 155-60.
47. Rommens, J.M., Iannuzzi, M.C., Kerem, B. et al. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 1989, 245: 1059-65.
48. Riordan, J.R., Rommens, J.M., Kerem, B. et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989, 245: 1066-80.
49. Mickle, J.E., Cutting, G.R. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations. Clin Chest Med 1998, 19: 443-58.
50. Sheppard, D.N., Welsh, M.J. Structure and function of the CFTR chloride channel. Physiol Rev 1999, 79: S23-45.
51. Ma, J., Davis, P.B. What we know and what we do not know about cystic fibrosis transmembrane conductance regulator. Clin Chest Med 1998, 19: 459-71.
52. Schwiebert, E.M., Flotte, T., Cutting, C.R., Guggino, W.B. Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents. Am J Physiol 1994, 266: C1464-77.
53. Stutts, M.J., Canessa, C.M., Olsen, J.C. et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 1995, 269: 847-50.
54. Welsh, M.J., Smith, A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993, 73: 1251-54.
55. Kerem, E., Kerem, B. Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 1996, 22: 387-95.
56. Zeitlin, P.L. Therapies directed at the basic defect in cystic fibrosis. Clin Chest Med 1998, 19: 515-25.
57. Elborn, J.S., Shale, D.J. Lung injury in cystic fibrosis. Thorax 1990, 45: 970-3.
58. Cantin, A. Cystic fibrosis lung inflammation: Early, sustained, and severe. Am J Respir Crit Care Med 1995, 151: 939-41.
59. Konstan, M.W., Berger, M. Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology. Pediatr Pulmonol 1997, 24: 137-42.
60. Crystal, R.G. Transfer of genes to humans: Early lessons and obstacles to success. Science 1995, 270: 404-10.
61. Rosenfeld, M.A., Collins, F.S. Gene therapy for cystic fibrosis. Chest 1996, 109: 241-52.
62. Robinson, C.B. Is DNA destiny? A cure for cystic fibrosis. Clin Chest Med 1998, 19: 527-34.
63. Zeitlin, P.L. Therapies directed at the basic defect in cystic fibrosis. Clin Chest Med 1998, 19: 515-25.
64. Brown, C.R., Hong-Brown, L.Q., Welch, W.J. Correcting temperature-sensitive protein folding defects. J Clin Invest 1997, 99: 1432-44.
65. Sato, S., Ward, C.L., Krouse, M.E., Wine, J.J., Kopito, R.R. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 1996, 271: 635-8.
66. Zeitlin, P.L., Rubenstein, R.C. Phenylbutyrate therapy for cystic fibrosis. Pediatr Pulmonol 1997, Suppl. 14: 132.
67. Cheng, S.H., Fang, S.L., Zabner, J. et al. Functional activation of the cystic fibrosis trafficking mutant deltaF508 CFTR by overexpression. Am J Physiol 1995, 268: L615-24.
68. Knowles, M.R., Clarke, L.L., Boucher, R.C. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 1991, 325: 533-8.
69. Bellanti, J.A., Zeligs, B.J., Kulcyzcki, L.L. Vaccinations against Pseudomonas aeruginosa: Active and passive alternatives. Pediatr Pulmonol 1997, Suppl. 16: 269-70.
70. Konstan, M.W. Therapies aimed at airway inflammation in cystic fibrosis. Clin Chest Med 1998, 19: 505-13.
71. Eigen, H., Rosenstein, B.J., Fitzsimmons, S., Schidlow, D. V. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 1995, 126: 515-23.